Murray Bern, MD
Hematology
Dr. Murray M. Bern, MD
|
|
Give Review
Murray Bern works in the field of Hematology. He went to Tulane University School of Medicine. He received 4 awards: "CMS Meaningful Use Stage 1 Certification", "Whos Who in Medicine and Healthcare", "Super Doctor" and "Top MD". Murray M. Bern, MD is also a published physician. He has 37 publication published. The most recent publication is: Phase I-II trial of 14 day infusional 6-mercaptopurine in advanced colorectal cancer. Murray Bern accepts Medicare payments and is registered with Medicare.gov.
Publications
- Multiple markers of hyperCoagulation in patients with history of venous thromboembolic disease.
- Failure to lyse venous thrombi because of elevated plasminogen activator Inhibitor 1 (PAI-1) and 4G polymorphism of its promotor genome (The PAI-1/4G Syndrome).
- Very low dose warfarin as prophylaxis against ultrasound detected Deep vein thrombosis following primary hip replacement.
- Effects of low-dose warfarin on antithrombin III levels in morbidly obese patients.
- Phase I-II trial of 14 day infusional 6-mercaptopurine in advanced coloRectal cancer.
- Pilot study of ambulatory infusional deLivery of a multidrug regimen: cisplatin, 5-fluorouracil and leucovorin (PFL) +/- etoposide.
- Pilot study of ambulatory infusional deLivery of a multidrug regimen: ifosfamide, carboplatin and etoposide (ICE).
- Multi-day fractionated administration schedule for paclitaxel.
- A phase I clinical trial of combined fluoropyrimidines with leucovorin in a 14-day infusion. Demonstration of biochemical modulation.
- Cyclosporin treatment for aplastic Anemia: a case report demonstrating a second response to second exposure to cyclosporin.
- Paclitaxel, cisplatin, etoposide combination chemotherapy: a multifractionated bolus dose schedule for non-small cell lung Cancer.
- Combined 5-fluorouracil and floxuridine administered as a 14-day infusion. A phase I study.
- Infusional carboplatin. Phase I studies of 5-day and 14-day infusions.
- Ifosfamide continuous infusion without mesna. A phase I trial of a 14-day cycle.
- Etoposide plus carboplatin admixture. Phase I study of five- or seven-day continuous infusion.
- Cyclophosphamide, methotrexate, and 5-fluorouracil in a three-drug admixture. Phase I trial of 14-day continuous ambulatory infusion.
- Low antithrombin III in morbid obesity: return to normal with weight reduction.
- A phase I study of thiotepa administered by short-term and proTracted continuous intravenous infusion.
- Pilot study of ambulatory infusional ifosfamide admixed with carboplatin.
- Combined floxuridine and cisplatin in a fourteen day infusion. Phase I study.
- Etoposide admixed with cisplatin. Phase I clinical investigation of 72-hour infusion.
- The multifractionated, twice-weekly dose schedule for a three-drug chemotherapy regimen: a phase I-II study of paclitaxel, cisplatin, and vinorelbine.
- Considerations for using lower doses of warfarin.
- Treatment of factor XI inhibitor using recombinant activated factor VIIa.
- Limitation of central Vein thrombosis in total parenteral nutrition by continuous infusion of low-dose heparin.
- A dose-escalation phase II clinical trial of infusional mitomycin C for 7 days in patients with advanced measurable coloRectal cancer refractory or resistant to 5-fluo...
- Paclitaxel, cisplatin and etoposide combination chemotherapy: a comparison of dose intensity in two multifractionated dose schemas.
- Dual modulation of 5-fluorouracil using leucovorin and hydroxyurea. A phase I trial.
- Combined paclitaxel, cisplatin, and etoposide for patients with previously untreated esophageal and gastroesophageal Carcinomas.
- Prophylaxis against central Vein thrombosis with low-dose warfarin.
- Very low doses of warfarin can prevent Thrombosis in central venous catheters. A randomized prospective trial.
- Autologous blood donation and subsequent blood use in patients undergoing total knee arthroplasty.
- Low-dose warfarin coupled with lower leg compression is effective prophylaxis against thromboembolic Disease after hip arthroplasty.
- Observations on possible effects of daily vitamin K replacement, especially upon warfarin therapy.
- Clinically significant pseudohyponatremia.
- Coagulopathy, following medical therapy, for Carcinoma of the prostate.
Schools
Tulane University School Of Medicine
New England Deaconess Hospital
Harvard SvcBoston City Hospital
Procedures Preformed
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Anemia
- Antiphospholipid Syndrome (APS)
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
- Choice Plus POS II
- Blue Card PPO
- Blue Cross Blue Shield of New Mexico PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- GHI PPO
- Fallon Community Health Plan
- Harvard Pilgrim Health Care PPO
- Humana
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Tufts Health Plans
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
- Whos Who in Medicine and Healthcare
- Super Doctor
- Top MD
Education
-
Beth Israel Deaconess Medical Center -
Boston University Medical Center -
Tulane University School of Medicine
Drug Facts
| NPI NUMBER | 1114990298 | |
| NPPES Provider LastName | BERN | |
| NPPES Provider FirstName | MURRAY | |
| NPPES Provider ZIPCode | 871310001 | |
| NPPES Provider State | NM | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 370.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1114990298 |
| Last Name Of The Provider | BERN |
| First Name Of The Provider | MURRAY |
| View All |
Similar Doctors
|
|
Ilene A. Galinsky |
|
|
Dr. Judith C. Lin, MD |
|
|
Dr. Mary L. Peters, MD |
|
|
Dr. Shom Goel, MD |
|
|
Dr. Leena Gandhi, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew J. Wagner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dimitrios Tzachanis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brett Glotzbecker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elisabeth M. Battinelli, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karen Quillen, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|